LRI Investments LLC Purchases 747 Shares of MetLife, Inc. (NYSE:MET)

LRI Investments LLC lifted its position in shares of MetLife, Inc. (NYSE:MET) by 308.7% during the 3rd quarter, Holdings Channel reports. The firm owned 989 shares of the financial services provider’s stock after purchasing an additional 747 shares during the quarter. LRI Investments LLC’s holdings in MetLife were worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of MET. PFG Investments LLC increased its position in MetLife by 8.9% during the third quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock worth $525,000 after buying an additional 520 shares during the last quarter. M&G Plc acquired a new position in shares of MetLife during the 2nd quarter worth approximately $2,346,000. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in MetLife in the 3rd quarter valued at $2,960,000. Segall Bryant & Hamill LLC acquired a new stake in MetLife during the 3rd quarter valued at $1,074,000. Finally, PGGM Investments boosted its position in MetLife by 1,803.4% during the second quarter. PGGM Investments now owns 69,796 shares of the financial services provider’s stock worth $4,899,000 after purchasing an additional 66,129 shares during the period. 89.81% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Jefferies Financial Group raised their target price on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 27th. Wells Fargo & Company boosted their price objective on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Barclays lowered their target price on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Thursday, October 31st. TD Cowen boosted their price target on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Finally, Morgan Stanley lowered their price objective on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Fourteen research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $88.62.

MetLife Trading Down 0.6 %

MET opened at $81.77 on Wednesday. The stock has a market capitalization of $56.62 billion, a price-to-earnings ratio of 16.49, a P/E/G ratio of 0.78 and a beta of 1.06. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a twelve month low of $64.17 and a twelve month high of $89.05. The company has a 50-day simple moving average of $83.78 and a 200 day simple moving average of $77.13.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be paid a $0.545 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.67%. MetLife’s dividend payout ratio (DPR) is 43.95%.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.